Sarepta Therapeutics, Inc. (SRPT) ownership: Top institutional holder: BlackRock, Inc. ($321.07M). Insider activity: Net Buyer (18 buys, 2 sells). 7 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 14755277.00 | $321.07M | 2026-03-31 |
| VANGUARD GROUP INC | 11810729.00 | $254.17M | 2025-12-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6640692.00 | $144.50M | 2026-03-31 |
| STATE STREET CORP | 6613314.00 | $143.91M | 2026-03-31 |
| AQR CAPITAL MANAGEMENT LLC | 6433112.00 | $138.63M | 2026-03-31 |
| TWO SIGMA INVESTMENTS, LP | 4593195.00 | $99.95M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4578235.00 | $99.62M | 2026-03-31 |
| FIRST TRUST ADVISORS LP | 4135788.00 | $89.99M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-03-12 | |
| Buy | null | 2026-03-11 | |
| Buy | null | 2026-03-11 | |
| Buy | null | 2026-03-11 | |
| Buy | null | 2026-03-11 | |
| Buy | null | 2026-03-09 | |
| Buy | null | 2026-03-09 | |
| Buy | null | 2026-03-09 |
Back to SRPT overview · SRPT earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.